{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T02:37:47Z","timestamp":1792723067677,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100017540","name":"National Heart Lung and Blood Institute Division of Intramural Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ajpath.2026.08.007","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:07:15Z","timestamp":1790035635000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immunologically Active Cardiac Fibroblasts Expressing Major Histocompatibility Complex-II Promote Doxorubicin Cardiotoxicity"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7583-4876","authenticated-orcid":false,"given":"Maria A.","family":"Zambrano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7534-6354","authenticated-orcid":false,"given":"Abraham L.","family":"Bayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramon B.","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2712-2149","authenticated-orcid":false,"given":"Constanza","family":"Stortini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8075-5678","authenticated-orcid":false,"given":"Kuljeet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Bedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8093-4465","authenticated-orcid":false,"given":"Kenneth B.","family":"Margulies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3013-3982","authenticated-orcid":false,"given":"Pilar","family":"Alcaide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2026.08.007_bib1","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0006-2952(98)00307-4","article-title":"A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics Adriamycin and daunorubicin","volume":"57","author":"Gewirtz","year":"1999","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.ajpath.2026.08.007_bib2","doi-asserted-by":"crossref","first-page":"25535","DOI":"10.1074\/jbc.M400944200","article-title":"Doxorubicin induces apoptosis in normal and tumor cells via distinctly different mechanisms: intermediacy of H(2)O(2)- and p53-dependent pathways","volume":"279","author":"Wang","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2026.08.007_bib3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41514-024-00135-7","article-title":"A review of the pathophysiological mechanisms of doxorubicin-induced cardiotoxicity and aging","volume":"10","author":"Linders","year":"2024","journal-title":"NPJ Aging"},{"key":"10.1016\/j.ajpath.2026.08.007_bib4","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1253\/jcj.43.1000","article-title":"Cardiotoxicity of anthracycline antineoplastic drugs--clinicopathological and experimental studies","volume":"43","author":"Suzuki","year":"1979","journal-title":"Jpn Circ J"},{"key":"10.1016\/j.ajpath.2026.08.007_bib5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/ejhf.654","article-title":"2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: the Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)","volume":"19","author":"Zamorano","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ajpath.2026.08.007_bib6","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.118.005234","article-title":"Doxorubicin exposure causes subacute cardiac atrophy dependent on the striated muscle-specific ubiquitin ligase MuRF1","volume":"12","author":"Willis","year":"2019","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.ajpath.2026.08.007_bib7","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.004560","article-title":"Left ventricular mass change after anthracycline chemotherapy","volume":"11","author":"Jordan","year":"2018","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.ajpath.2026.08.007_bib8","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/j.amjcard.2012.07.040","article-title":"Left ventricular mass in patients with a cardiomyopathy after treatment with anthracyclines","volume":"110","author":"Neilan","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ajpath.2026.08.007_bib9","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1056\/NEJM198107163050305","article-title":"The anthracycline antineoplastic drugs","volume":"305","author":"Young","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpath.2026.08.007_bib10","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/s44161-024-00507-y","article-title":"Cytotoxic T cells drive doxorubicin-induced cardiac fibrosis and systolic dysfunction","volume":"3","author":"Bayer","year":"2024","journal-title":"Nat Cardiovasc Res"},{"key":"10.1016\/j.ajpath.2026.08.007_bib11","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.3390\/ijms26094071","article-title":"Interleukin-6 in anthracycline-related cardiac dysfunction: a comparison with myeloperoxidase and TNF-alpha","volume":"26","author":"Borowiec","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajpath.2026.08.007_bib12","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.43882","article-title":"Single-cell expression profiling reveals dynamic flux of cardiac stromal, vascular and immune cells in health and injury","volume":"8","author":"Farbehi","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.ajpath.2026.08.007_bib13","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1172\/JCI98215","article-title":"Specialized fibroblast differentiated states underlie scar formation in the infarcted mouse heart","volume":"128","author":"Fu","year":"2018","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2026.08.007_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12260","article-title":"Genetic lineage tracing defines myofibroblast origin and function in the injured heart","volume":"7","author":"Kanisicak","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajpath.2026.08.007_bib15","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.yjmcc.2015.11.020","article-title":"Computational modeling of cardiac fibroblasts and fibrosis","volume":"93","author":"Zeigler","year":"2016","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.ajpath.2026.08.007_bib16","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1161\/CIRCULATIONAHA.116.026238","article-title":"Fibroblast-specific genetic manipulation of p38 mitogen-activated protein kinase in vivo reveals its central regulatory role in fibrosis","volume":"136","author":"Molkentin","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.ajpath.2026.08.007_bib17","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/s41586-020-2797-4","article-title":"Cells of the adult human heart","volume":"588","author":"Litvinukova","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2026.08.007_bib18","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1161\/CIRCULATIONAHA.119.043053","article-title":"Single-cell reconstruction of progression trajectory reveals intervention principles in pathological cardiac hypertrophy","volume":"141","author":"Ren","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.ajpath.2026.08.007_bib19","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41556-019-0446-7","article-title":"Single-cell reconstruction of the adult human heart during heart failure and recovery reveals the cellular landscape underlying cardiac function","volume":"22","author":"Wang","year":"2020","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.ajpath.2026.08.007_bib20","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41577-024-00994-x","article-title":"The regulation and differentiation of regulatory T cells and their dysfunction in autoimmune diseases","volume":"24","author":"Sumida","year":"2024","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ajpath.2026.08.007_bib21","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/s44161-022-00116-7","article-title":"Antigen presentation by cardiac fibroblasts promotes cardiac dysfunction","volume":"1","author":"Ngwenyama","year":"2022","journal-title":"Nat Cardiovasc Res"},{"key":"10.1016\/j.ajpath.2026.08.007_bib22","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1161\/CIRCHEARTFAILURE.115.002225","article-title":"Left ventricular T-cell recruitment contributes to the pathogenesis of heart failure","volume":"8","author":"Nevers","year":"2015","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.ajpath.2026.08.007_bib23","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1084\/jem.20161791","article-title":"Th1 effector T cells selectively orchestrate cardiac fibrosis in nonischemic heart failure","volume":"214","author":"Nevers","year":"2017","journal-title":"J Exp Med"},{"key":"10.1016\/j.ajpath.2026.08.007_bib24","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1093\/cvr\/cvag098","article-title":"STING promotes CD8 T-cell cardiotropism and fibrosis from distinct cellular compartments in doxorubicin cardiomyopathy","volume":"122","author":"Bayer","year":"2026","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ajpath.2026.08.007_bib25","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1161\/CIRCULATIONAHA.124.071217","article-title":"Human single-nucleus RNA sequencing identifies CD47 as a therapeutic target for doxorubicin-induced cardiomyopathy","volume":"152","author":"Guo","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.ajpath.2026.08.007_bib26","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1161\/CIRCRESAHA.124.325527","article-title":"Transcription factor 21 regulates cardiac myofibroblast formation and fibrosis","volume":"136","author":"Johansen","year":"2025","journal-title":"Circ Res"},{"key":"10.1016\/j.ajpath.2026.08.007_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/srep17948","article-title":"PDGFRalpha plays a crucial role in connective tissue remodeling","volume":"5","author":"Horikawa","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajpath.2026.08.007_bib28","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.164380","article-title":"Functional Pdgfra fibroblast heterogeneity in normal and fibrotic mouse lung","volume":"8","author":"Trempus","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.ajpath.2026.08.007_bib29","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1126\/science.1198687","article-title":"Innate or adaptive immunity? the example of natural killer cells","volume":"331","author":"Vivier","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.ajpath.2026.08.007_bib30","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/qjmed\/hci112","article-title":"Clinical and immunological aspects of HLA class I deficiency","volume":"98","author":"Zimmer","year":"2005","journal-title":"QJM"},{"key":"10.1016\/j.ajpath.2026.08.007_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110587","article-title":"Temporary blockade of interferon-gamma ameliorates doxorubicin-induced cardiotoxicity without influencing the anti-tumor effect","volume":"130","author":"Ma","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.ajpath.2026.08.007_bib32","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.abn8017","article-title":"Doxorubicin causes ferroptosis and cardiotoxicity by intercalating into mitochondrial DNA and disrupting Alas1-dependent heme synthesis","volume":"15","author":"Abe","year":"2022","journal-title":"Sci Signal"},{"key":"10.1016\/j.ajpath.2026.08.007_bib33","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/s41419-021-03614-x","article-title":"Regulated cell death pathways in doxorubicin-induced cardiotoxicity","volume":"12","author":"Christidi","year":"2021","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.ajpath.2026.08.007_bib34","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000097977","article-title":"Interferon-beta is a potent inducer of interferon regulatory factor-1\/2-dependent IP-10\/CXCL10 expression in primary human endothelial cells","volume":"44","author":"Buttmann","year":"2007","journal-title":"J Vasc Res"},{"key":"10.1016\/j.ajpath.2026.08.007_bib35","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/ana.410400412","article-title":"Interferon beta induces interleukin-10 expression: relevance to multiple sclerosis","volume":"40","author":"Rudick","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ajpath.2026.08.007_bib36","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1016\/j.cell.2023.05.039","article-title":"Cooperative sensing of mitochondrial DNA by ZBP1 and cGAS promotes cardiotoxicity","volume":"186","author":"Lei","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.ajpath.2026.08.007_bib37","doi-asserted-by":"crossref","first-page":"6534","DOI":"10.1111\/jcmm.15305","article-title":"Effects of doxorubicin-induced cardiotoxicity on cardiac mitochondrial dynamics and mitochondrial function: insights for future interventions","volume":"24","author":"Osataphan","year":"2020","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.ajpath.2026.08.007_bib38","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0378-4274(01)00329-0","article-title":"Doxorubicin-induced persistent oxidative stress to cardiac myocytes","volume":"121","author":"Zhou","year":"2001","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.ajpath.2026.08.007_bib39","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.cardfail.2023.10.477","article-title":"Sex differences in the development of anthracycline-associated heart failure","volume":"30","author":"Diaz","year":"2024","journal-title":"J Card Fail"},{"key":"10.1016\/j.ajpath.2026.08.007_bib40","doi-asserted-by":"crossref","DOI":"10.1002\/adtp.202400036","article-title":"Sex differences in doxorubicin-induced cardiotoxicity: insights from transcriptome analysis","volume":"7","author":"Su","year":"2024","journal-title":"Adv Therap"},{"key":"10.1016\/j.ajpath.2026.08.007_bib41","doi-asserted-by":"crossref","first-page":"8037","DOI":"10.1038\/s41598-021-87006-3","article-title":"Sex and tamoxifen confound murine experimental studies in cardiovascular tissue engineering","volume":"11","author":"Blum","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajpath.2026.08.007_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.physiol.010908.163156","article-title":"Sex-based cardiac physiology","volume":"71","author":"Luczak","year":"2009","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.ajpath.2026.08.007_bib43","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/cvr\/cvaa155","article-title":"Improving translational research in sex-specific effects of comorbidities and risk factors in ischaemic heart disease and cardioprotection: position paper and recommendations of the ESC Working Group on Cellular Biology of the Heart","volume":"117","author":"Perrino","year":"2021","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ajpath.2026.08.007_bib44","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.96753","article-title":"Highly potent visnagin derivatives inhibit Cyp1 and prevent doxorubicin cardiotoxicity","volume":"3","author":"Asnani","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.ajpath.2026.08.007_bib45","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/BF00685539","article-title":"Comparative pharmacokinetics of doxorubicin given by three different schedules with equal dose intensity in patients with breast cancer","volume":"28","author":"Twelves","year":"1991","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.ajpath.2026.08.007_bib46","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1161\/CIRCULATIONAHA.108.799700","article-title":"Acute doxorubicin cardiotoxicity is associated with p53-induced inhibition of the mammalian target of rapamycin pathway","volume":"119","author":"Zhu","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ajpath.2026.08.007_bib47","doi-asserted-by":"crossref","first-page":"5512","DOI":"10.3390\/ijms24065512","article-title":"Tamoxifen modulates the immune landscape of the tumour microenvironment: the paired siglec-5\/14 checkpoint in anti-tumour immunity in an in vitro model of breast cancer","volume":"24","author":"Wielgat","year":"2023","journal-title":"Int J Mol Sci"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944026002592?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944026002592?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:49:49Z","timestamp":1792720189000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944026002592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":47,"alternative-id":["S0002944026002592"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2026.08.007","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunologically Active Cardiac Fibroblasts Expressing Major Histocompatibility Complex-II Promote Doxorubicin Cardiotoxicity","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2026.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Investigative Pathology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}